RPS26P21

Across TCGA pan-cancer cohorts, RPS26P21 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPS26P21 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPS26P21 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS26P21 expression acts as an unfavorable survival marker, although some lineages such as GBM and HNSC show a favorable association.

BLCA, KICH, and GBM are the cancer types where RPS26P21 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	II,III,IV	0.542	0.665	.010	33	view →
KICH	DFS	Quartile	II,III,IV	0.706	1.000	.017	32	view →
GBM	OS	Tertile	All	0.518	0.334	<.001	24	view →
HNSC	DFS	Median	III,IV	0.361	0.273	.014	22	view →
LGG	OS	Tertile	All	0.636	0.420	.002	17	view →
LAML	DFS	Median	All	0.377	0.558	.020	14	view →
KIRP	OS	Median	III,IV	0.869	0.669	.018	13	view →
TGCT	DFS	Tertile	All	0.550	0.815	.021	12	view →
UCS	DFS	Tertile	IV	0.981	0.561	.017	12	view →
SKCM	OS	Median	IV	0.673	0.198	.021	10	view →
ESCA	OS	Median	III,IV	0.602	0.316	.005	9	view →
CHOL	OS	Quartile	All	1.000	0.367	.028	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPS26P21–BLCA (DFS)

Open the BLCA breakdown →